Literature DB >> 2002633

Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney.

S Horikoshi1, S Kubota, G R Martin, Y Yamada, P E Klotman.   

Abstract

The mechanisms responsible for renal cyst formation in congenital polycystic kidney disease remain unknown, although abnormalities of cellular metabolism, basement membrane components, and growth factors have been suggested. In the present study, we examined a potential role for epidermal growth factor (EGF) in cyst formation in a mouse model. We measured growth factor activity and concentration in renal cyst fluid, urine, and serum obtained from mice with congenital polycystic kidney disease (cpk). In affected mice, both growth factor activity of urine and the urinary EGF concentration were much lower than unaffected littermate controls even when corrected for creatinine concentration. Although the growth factor activity was much lower in affected mice, there were significant differences in the regional distribution of EGF in animals with cysts. Both growth factor activity and EGF concentration were greater in cyst fluid when compared to urine. Growth factor activity in cysts was completely inhibited by anti-EGF antibody using BALB/MK epithelial keratinocytes as targets. The expression of EGF mRNA in kidneys from affected mice was markedly decreased when compared to littermate controls. These results suggest that decreased EGF production and local differences in EGF concentration may contribute to cyst formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002633     DOI: 10.1038/ki.1991.7

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

3.  A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.

Authors:  R Pey; J Bach; G Schieren; N Gretz; M Hafner
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

4.  Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.

Authors:  W G Richards; W E Sweeney; B K Yoder; J E Wilkinson; R P Woychik; E D Avner
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.

Authors:  Yasunori Sato; Kenichi Harada; Kazuo Kizawa; Takahiro Sanzen; Shinichi Furubo; Mitsue Yasoshima; Satoru Ozaki; Masahiko Ishibashi; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  Transforming growth factor alpha and epidermal growth factor expression in experimental murine polycystic kidney disease.

Authors:  M R Ogborn; S Sareen
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 7.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

8.  A urinary biomarker profile for children with HIV-associated renal diseases.

Authors:  Angel A Soler-García; Natella Y Rakhmanina; Parnell C Mattison; Patricio E Ray
Journal:  Kidney Int       Date:  2009-04-08       Impact factor: 10.612

9.  Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Authors:  Laura R Harskamp; Ron T Gansevoort; Wendy E Boertien; Wim van Oeveren; Gerwin E Engels; Harry van Goor; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

Review 10.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.